首页> 外文期刊>Archivio Italiano di Urologia e Andrologia >Role of sterile pyuria in association to elevated PSA values in the diagnosis of non-palpable prostate cancer?
【24h】

Role of sterile pyuria in association to elevated PSA values in the diagnosis of non-palpable prostate cancer?

机译:无菌性脓尿与升高的PSA值相关联在诊断不可触及的前列腺癌中的作用?

获取原文
           

摘要

Objectives: Although cancer is believed to develop and progress with the involvement of inflammation, it is still unclear what the correlation between inflammation and prostate cancer is. This study based on results of transrectal ultrasound-guided prostate biopsies aimed to determine whether C-reactive protein (CRP) and sterile pyuria were clinically useful in the evaluation of patients with suspect of prostate cancer. Materials and methods: This study is a cross-sectional prospective study of patients without clinical prostatitis symptoms. Characteristics of the 200 consecutive patients recruited were 3-20 ng/mL value of serum prostate-specific antigen (PSA), normal digital rectal examination finding, and sterile urine culture result. All patients underwent 12-core prostatic biopsy. 163 of the 200 patients had benign prostatic hyperplasia confirmed through histology, while the residual 37 patients had prostate cancer. Patients with pre-treatment urinary leukocyte count ≤ 3/high power field were categorized as non-pyuria, whilst those with pre-treatment urinary leukocyte count 3/high power field were categorized as pyuria. The serum CRP level was also used to differentiate patients before the biopsy. Subgroups were compared regarding a number of clinical variables. Results: Histology revealed that 70% of pyuria patients and 38.5% of non-pyuria patients presented inflammation (p = 0.001). The pyuria group exhibited significantly higher total PSA compared to the non-pyuria group (p = 0.044). The two groups did not differ significantly regarding cancer detection rate (p = 0.752). CRP groups were similar regarding cancer detection and histologically-detected inflammation rates. Conclusion: In patients with no evidence of clinical prostatitis, sterile pyuria should be considered as a cause of increased PSA. Although sterile pyuria cannot predict non-palpable prostate cancer, it should be taken into account in urological evaluation in order to demonstrate minute prostatic inflammation due to its simplicity, convenience and non-invasiveness.
机译:目的:尽管人们认为癌症会随着炎症的发展而发展,但仍不清楚炎症与前列腺癌之间的相关性。这项研究基于经直肠超声引导的前列腺活检结果,旨在确定C反应蛋白(CRP)和无菌脓尿在临床上是否可用于评估可疑前列腺癌患者。材料和方法:本研究是对没有临床前列腺炎症状的患者进行的前瞻性研究。连续招募的200名患者的特征是血清前列腺特异性抗原(PSA)的值为3-20 ng / mL,直肠指检正常,无菌尿培养结果。所有患者均接受了12芯前列腺活检。经组织学证实,在200名患者中,有163名患有良性前列腺增生,而其余37名患者则患有前列腺癌。术前尿白细胞计数≤3 /高倍视野的患者被归为非脓尿,而术前尿白细胞计数≥3 /高倍视野的患者被归为脓尿。血清CRP水平还用于在活检之前区分患者。比较了许多临床变量的亚组。结果:组织学检查显示,有70%的脓尿患者和38.5%的非脓尿患者出现炎症(p = 0.001)。与非脓尿组相比,脓尿组表现出明显更高的总PSA(p = 0.044)。两组的癌症检出率无显着差异(p = 0.752)。 CRP组在癌症检测和组织学检测的炎症发生率方面相似。结论:在无临床前列腺炎迹象的患者中,无菌性脓尿应被视为增加PSA的原因。尽管无菌性脓尿不能预测不可触及的前列腺癌,但由于其简单性,便利性和非侵入性,在泌尿科评估中应考虑到它,以证明微小的前列腺炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号